NISA INVESTMENT ADVISORS, LLC

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 937615 ST. LOUIS, MO

Position in FENC

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$494

+$212 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#97

of 104 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. FENC ranks #244 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	56,455	$28,042,892
2	REGN	Regeneron Pharmaceuticals, Inc.	19,412	$12,104,158
3	TECH	BIO-TECHNE Corp	68,452	$4,836,133
4	INCY	Incyte Corp	26,479	$3,001,659
5	ALNY	Alnylam Pharmaceuticals, Inc.	9,139	$2,751,113
6	DFTX	Definium Therapeutics, Inc.	48,369	$2,275,277
7	PRAX	Praxis Precision Medicines, Inc.	6,111	$2,045,901
8	EXEL	Exelixis, Inc.	36,758	$2,000,002

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$494	46	0.0%	Shares	Sole	2026-08-10
2026-03-31	$282	46	0.0%	Shares	Sole	2026-04-30
2025-12-31	$354	46	0.0%	Shares	Sole	2026-01-15
2025-09-30	$430	46	0.0%	Shares	Sole	2025-10-23
2025-06-30	$381	46	-79.7%	Shares	Sole	2025-07-31
2025-03-31	$1,382	227	-39.8%	Shares	Sole	2025-04-30
2024-12-31	$2,382	377	+40.1%	Shares	Sole	2025-01-17
2024-09-30	$1,345	269	+289.9%	Shares	Sole	2024-10-24
2024-06-30	$421	69	-95.4%	Shares	Sole	2024-07-19
2021-03-31	$9,315	1,500	0.0%	Shares	Sole	2021-04-26
2020-12-31	$11,175	1,500	—	Shares	Sole	2021-01-25
No filing history on record for this holder in this stock.